Ikarian Capital’s AstraZeneca AZN Stock Holding History

Ikarian Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-546	Closed	-$8.52M	–	155
2024 Q2	$8.52M	Sell	546 -154,054	-100%	-$23.2M	1.48%	21
2024 Q1	$20.9M	Buy	+154,600	New	+$20.5M	2.3%	9
2023 Q3	–	Sell	-125,000	Closed	-$17.9M	–	148
2023 Q2	$17.9M	Buy	+125,000	New	+$18.4M	2.85%	7
2021 Q4	–	Sell	-50,000	Closed	-$6.01M	–	195
2021 Q3	$6.01M	Buy	+50,000	New	+$5.82M	0.42%	56
2021 Q2	–	Sell	-175,000	Closed	-$17.4M	–	223
2021 Q1	$17.4M	Hold	175,000	–	–	0.59%	37
2020 Q4	$17.5M	Buy	+175,000	New	+$18.5M	0.77%	28

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return